Precision Targeting of Na+/H+ Exchange: A New Era for Endoth
2026-05-22
This thought-leadership article explores the transformative potential of 5-(N,N-dimethyl)-Amiloride hydrochloride in translational models of endothelial injury and cardiac dysfunction. Integrating mechanistic insights, recent biomarker discoveries, and strategic experimental guidance, it positions APExBIO’s inhibitor as a catalyst for next-generation research into vascular integrity, intracellular pH regulation, and ischemia-reperfusion injury.
Oltipraz (SKU B5958): Reliable Nrf2 Activation in Cell Assay
2026-05-21
This article offers evidence-driven guidance for using Oltipraz (SKU B5958) in cell viability, proliferation, and cytotoxicity assays. Drawing on real laboratory scenarios, it addresses experimental design, optimization, and product selection, with emphasis on reproducibility and workflow compatibility. APExBIO's Oltipraz is highlighted for its purity, stability, and robust Nrf2 pathway activation.
ERAD-Hijacking Chimeras Enable Selective TM Protein Degradat
2026-05-21
Song et al. introduce ERAD-engaging chimeras (ERADECs), a novel technology that harnesses the ER-associated degradation (ERAD) pathway for targeted removal of transmembrane proteins. This strategy overcomes significant barriers in current targeted protein degradation (TPD) approaches and demonstrates potent efficacy against challenging targets such as PD-L1, with implications for future drug discovery and mechanistic studies.
ERAD-Hijacking Chimeras: Targeted Degradation of TM Proteins
2026-05-20
Song et al. introduce ERAD-engaging chimeras (ERADECs), a small-molecule platform that enables precise degradation of transmembrane proteins by co-opting the ER-associated degradation pathway. This method achieves sub-nanomolar efficacy for targets like PD-L1, representing a major advance in targeted protein degradation with significant implications for drug discovery and membrane protein research.
Viral-Induced RIPK3 Degradation Controls Necroptosis and Inf
2026-05-20
This study uncovers a mechanism in orthopoxviruses—particularly cowpox virus—whereby a viral protein (vIRD) induces the degradation of the necroptosis adaptor RIPK3, suppressing necroptosis and modulating virus-induced inflammation. These findings highlight a pivotal host-pathogen interaction, informing future research on immune evasion and therapeutic targeting of ubiquitin-proteasome pathways.
2-Deoxy-D-glucose: Precision Metabolic Modulation for Transl
2026-05-19
This article explores the mechanistic, experimental, and translational dimensions of 2-Deoxy-D-glucose (2-DG) in cancer and metabolic research, drawing connections between glycolysis inhibition, insulin-independent glucose uptake, and the future of precision therapies. Emphasizing APExBIO's high-purity 2-DG, it provides actionable guidance for researchers aiming to bridge fundamental metabolism with applied translational strategies.
NAD+ as a Metabolic Checkpoint: Redefining Energy Stress Ass
2026-05-19
Explore how Nicotinamide Adenine Dinucleotide (NAD+) functions as a metabolic checkpoint in energy stress, revealing new assay opportunities beyond traditional pathways. This in-depth article provides unique scientific insights grounded in recent paradigm-shifting research.
Amyloid β-Peptide (1-42): Optimizing Neurotoxicity Assays in
2026-05-18
Leverage Amyloid β-Peptide (1-42) (Aβ42) for reproducible, high-content Alzheimer’s disease research with validated protocols and troubleshooting insights. This guide translates breakthrough findings into actionable workflows, ensuring robust and interpretable results in neurotoxicity and ion channel modulation assays.
DOT1L Inhibition by EPZ5676 Attenuates Renal Fibrosis via H3
2026-05-18
This study demonstrates that inhibition of the histone methyltransferase DOT1L with EPZ5676 reduces renal fibrosis in a murine model by suppressing fibroblast activation and epithelial-mesenchymal transition. The findings suggest that DOT1L-mediated H3K79 methylation is a key driver of profibrotic signaling in chronic kidney disease, highlighting a new potential therapeutic target.
Sumatriptan’s Anti-Inflammatory Actions: Systematic Review I
2026-05-17
This systematic review reveals that sumatriptan, beyond its established role as an anti-migraine agent, exerts significant anti-inflammatory effects by modulating cytokine production, nitric oxide pathways, and neuropeptide release. The findings suggest potential for drug repurposing in inflammatory disorders, with broad relevance for pharmacological research and translational oncology.
L-NAME Hydrochloride in NO Signaling: Mechanistic Insights &
2026-05-16
Discover L-NAME Hydrochloride's advanced role as a NOS inhibitor in nitric oxide research, with a unique focus on apoptosis and inflammation pathway modulation. This article delivers mechanistic depth and protocol guidance for translational cardiovascular and renal research.
Temafloxacin: Advanced Insights for Antibacterial Research D
2026-05-15
Explore the scientific foundations and advanced applications of Temafloxacin, a fluoroquinolone broad-spectrum antibacterial agent. This article offers new assay guidance and critical analysis for researchers working on Gram-positive and Gram-negative bacterial infections.
V5 Epitope Tag Peptide: Precision Tagging for Advanced Prote
2026-05-15
The V5 Epitope Tag Peptide enables robust, high-specificity protein tagging for dynamic detection and purification workflows. Leveraging recent innovations in single-molecule antibody screening, this tag empowers multiplexed imaging and reproducible results across Western blot, immunoprecipitation, and super-resolution microscopy.
High-Throughput BBB Permeability: LLC-PK1-MOCK/MDR1 Model Ad
2026-05-14
This study establishes a high-throughput, physiologically relevant in vitro blood-brain barrier (BBB) model using LLC-PK1-MOCK/MDR1 cells, with correction for lysosomal trapping. The model enables accurate, rapid screening of CNS drug candidates for BBB permeability, streamlining early-stage drug development and reducing reliance on animal studies.
Plant Exosome-like Nanovesicles Mitigate Testicular Injury v
2026-05-14
This study demonstrates that exosome-like nanovesicles from Cistanche deserticola selectively target Sertoli cells and alleviate cyclophosphamide-induced testicular injury by modulating cell cycle arrest through miRNA-mediated mechanisms. The findings reveal a novel cross-kingdom regulatory pathway and highlight potential strategies for protecting male fertility.
462 records 18/31 page Previous Next First page 上5页 1617181920 下5页 Last page